Special Advertising

NPS Pharmaceuticals Inc. (NPSP) Stock Quote

Detailed Quote for NPS Pharmaceuticals Inc. (NPSP)
$ 32.00   0.40 (+1.27%) Volume: 1.87m 4:00 PM EST Nov 21, 2014
After Hours:  $ 32.00 0.00 (0.00%) Volume: 16.35k 7:42 PM EST Nov 21, 2014
Today 5d 1m 3m 1y more
Last Price
32.00
Change $
0.40
Change %
1.27%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
32.00
High
32.15
Low
31.29
Prev Close
31.60
Last Trade
11/21/14
Volume
1.87m
52 Wk Hi
39.68
52 Wk Low
22.11
Market Cap
3.42b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
106,839,708
EPS (TTM)
0.02
PE Ratio
N/A
Exchange
NGS
News and Media for NPS Pharmaceuticals Inc. (NPSP)
Sector News | Topic News
News for NPS Pharmaceuticals Inc. (NPSP)
Tue, Nov 11, 2014
4:10 PM NPS Pharma to Present at Jefferies Global Healthcare Conference - Business Wire
Mon, Nov 10, 2014
10:22 PM NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q3 2014 Results - Earnings Call Transcript - SeekingAlpha
4:25 PM NPS Pharmaceuticals (NPSP) Q3 2014 Results - Earnings Call Webcast - SeekingAlpha
4:08 PM NPS Pharmaceuticals misses by $0.04, misses on revenue - SeekingAlpha
4:01 PM NPS Pharma Reports Third-Quarter 2014 Financial Results - Business Wire
Sun, Nov 09, 2014
5:35 PM Notable earnings after Monday's close - SeekingAlpha
Fri, Nov 07, 2014
8:53 AM NPS Pharmaceuticals - Why We Don't Agree With Price Targets But Still See 15% Upside - SeekingAlpha
Tue, Nov 04, 2014
4:30 PM NPS Pharma Appoints Pierre Legault to Board of Directors - Business Wire
Mon, Nov 03, 2014
8:10 AM NPS Pharma to Report Third Quarter 2014 Financial Results - Business Wire
Thu, Oct 23, 2014
4:34 PM PDUFA Action Date for Natpara\u00AE BLA Extended Three Months to January 24, 2015 - Business Wire
Wed, Sep 24, 2014
4:10 PM NPS Pharma to Present at Leerink Partners Rare Disease Roundtable - Business Wire
Fri, Sep 12, 2014
5:06 PM FDA Advisory Committee Recommends Approval of Natpara\u00AE for Long-Term Treatment of Hypoparathyroidism - Business Wire
7:06 AM NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara\u00AE Biologics License Application - Business Wire
Wed, Sep 10, 2014
2:00 PM NPS Pharmaceuticals Inc. (NPSP) Jumps 25.11% on September 10 - Equities.com
8:04 AM FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara\u00AE for Hypoparathyroidism - Business Wire
Tue, Sep 09, 2014
2:02 PM NPS Pharmaceuticals Inc. (NPSP) Drops 9.77% on September 9 - Equities.com
Thu, Sep 04, 2014
1:41 PM NPS Pharmaceuticals Inc. (NPSP) Drops 8.49% on September 4 - Equities.com
Tue, Aug 26, 2014
10:31 AM NPS Pharmaceuticals Inc. (NPSP) Jumps 6.07% on August 26 - Equities.com
Wed, Aug 06, 2014
4:30 PM NPS Pharma Reports Second-Quarter 2014 Financial Results - Business Wire
Tue, Aug 05, 2014
8:10 AM NPS Pharma to Present at Upcoming Conferences - Business Wire
More News for NPSP >>

Tags for NPS Pharmaceuticals Inc.

Research stocks or mutual funds related to NPS Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to NPSP. The keywords below have been associated to NPSP by either user submission or electronic means.

schering plough health care products biotechnology company pharmaceuticals research pharmaceuticals international research king report on corporate governance corporate governance quotient elite pharmaceuticals pharmaceutical industry strategy biotech conference pharmaceutical market corporate governance consulting corporate governance training pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics niche pharmaceutical investment products board of director biotechnology market pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter new innovative products Biological Products corporate governance calpers corporate governance governance consultant pharma manufacturing governance consulting corporate governance practices pharmaceuticals jobs pfizer pharmaceutical company novartis pharmaceuticals kv pharmaceutical company pharmaceuticals supply chain corporate law warrick pharmaceutical corporate governance issues licensed products generic products corporate governance conference corporate governance ratings data monitoring committees pharmaceutical cro annual report printing pharma companies define corporate governance governance policy board of directors role